Amit Munshi, Director at Inhibikase Therapeutics, Inc. (IKT), bought 730,000 shares at $1.37 ($1.0M) on 2024-10-21, disclosed to the SEC on 2024-10-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.37 | 365,000 | $500K | 50.0% |
| 2 | $1.37 | 365,000 | $500K | 50.0% |
| Total | $1.37 avg | 730,000 | $1.0M | 100% |
| Filing → |
| ARNA | BUY | 2021-08-17 | $48K | — | Filing → |
| ARNA | BUY | 2021-08-13 | $50K | — | Filing → |
| ARNA | BUY | 2021-08-11 | $53K | — | Filing → |